This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

This transaction was executed in multiple trades during the day at prices ranging from $163.56 to $164.50. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $167.15 to $168.12. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $159.12 to $160.10. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $162.50 to $163.40. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $166.15 to $167.00. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $158.12 to $159.10. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Shares are held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

This transaction was executed in multiple trades during the day at prices ranging from $164.68 to $165.54. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $170.42 to $171.05. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $169.27 to $170.08. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $161.15 to $162.05. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $168.18 to $169.13. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $160.12 to $161.10. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2025.

Shares are held by Farquhar Investment Partnership No. 2.

/s/ Veena Bhatia, Attorney-in-Fact for Farquhar Scott


Common Stock

These shares are restricted and vest semi-annually, with 20% vesting in the first year and 40% vesting in each of the next two years following the grant date.

Represents the number of shares withheld by the Issuer upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the most recent prior market day.

Represents an award of restricted stock rights, each of which represents a contingent right to receive one share of the Company's common stock. The restricted stock rights will vest based on the achievement of certain compound annual growth rates in the price of the Company's common stock between the award date and September 15, 2028, subject to earlier vesting in certain circumstances described in the applicable award agreement. The amount reported herein represents the threshold amount under the award.


Common Stock


CLASS A COMMON STOCK

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock or, at the election of the Issuer, an equivalent cash payment.

Shares were sold to cover taxes upon the vesting of restricted stock units pursuant to a Rule 10b5-1 sell to cover instruction dated June 14, 2023.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.63, inclusive. The Reporting Person undertakes to
provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price
within the ranges set forth in this footnote.

The original grant of 11,800 RSUs has vested or will vest in four equal installments on each of the first through fourth anniversaries of August 8, 2024, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date.

/s/ Tracy D. Daw as Attorney-in-Fact for Yves Le Pendeven


Includes directly owned shares, restricted stock units and dividend equivalent units.


MACOM Technology Solutions Holdings, Inc.

The shares were sold pursuant to a sales plan adopted by the Reporting Person on August 21, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Reflects shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held (a) directly by the Mark & Robyn Jones Descendants Trust 2014 and (b) indirectly by Mark Evan Jones and Robyn Mary Elizabeth Jones, who serve as trustees of the Mark & Robyn Jones Descendants Trust 2014 and whose immediate family members are beneficiaries of the Mark & Robyn Jones Descendants Trust 2014.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.00 to $86.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.02 to $87.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Reflects shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held directly by Mark Evan Jones, and does not reflect shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held by his spouse, Robyn Mary Elizabeth Jones, who is independently a reporting person of the issuer.

Reflects shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held directly by Robyn Mary Elizabeth Jones, and does not reflect shares of Class A Common Stock, shares of Class B Common Stock, or LLC Units, as applicable, held by her spouse, Mark Evan Jones, who is independently a reporting person of the issuer.

Reflects shares of Class B Common Stock or LLC Units, as applicable, held indirectly by Mark Evan Jones and Robyn Mary Elizabeth Jones, who serve as trustees of various trusts and whose immediate family members are beneficiaries of such trusts.

Each LLC Unit, together with a share of Class B Common Stock, may be converted by the holder into one share of Class A Common Stock at any time. The LLC Units do not expire.


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $231.9360 to $232.7584 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $232.9777 to $233.9700 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $234.0682 to $235.0578 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $235.1232 to $236.0919 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $236.4300 to $237.4175 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $237.4497 to $238.1900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $238.5200 to $239.3514 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $239.7839 to $240.5928 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $241.0449 to $241.3877 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024 by the Reporting Person, with a plan end date of February 27, 2026.

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.992 to $14.12, inclusive. The Reporting Person hereby
undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective
price within the range set forth in this footnote.

Reporting Person's Title: Executive Vice President and Chief Medical Officer

/s/ Latha Vairavan, Attorney-in-Fact for Patrick Burnett


Reflects a grant of restricted stock units that vest on August 8, 2027.

Includes 1,140 shares acquired under the Avantor Employee Stock Purchase Plan.


Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.

/s/ Priscilla Duncan-Tannous, Attorney-in-Fact


Common Stock

Restricted Stock Units were granted to the Reporting Person pursuant to the Issuer's 2024 Equity Incentive Plan, each of which vested on the Transaction Date.


Common Stock

Common Stock

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 14, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.50 to $13.78, inclusive.

The options vest ratably on each of the first, second, third and fourth anniversaries of the grant date contingent on the reporting person's continuation in service on each applicable vesting date.

/s/ Christopher Hilberg, Attorney-in-Fact


Common Stock

Common Stock

Common Stock

This transaction was executed in multiple trades at prices ranging from $84.50 to $84.65; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

This transaction was executed in multiple trades at prices ranging from $84.50 to $84.63; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

This transaction was executed in multiple trades at prices ranging from $82.39 to $82.995; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

This transaction was executed in multiple trades at prices ranging from $83.00 to $83.53; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Stock Option performance grant becomes eligible to vest with 20-day average closing price that meets or exceeds the stock price target within 5 year period with continued service of 3 year from the date of grant. 33.33% of the option will vest if stock price target is $45.66. 66.66% of the option will vest if stock price target is $49.81. 100% of the option will vest if stock price target is $53.96.


Common Stock

The Issuer entered into a Securities Purchase Agreement (the "SPA") with certain investors (collectively, the "Purchasers"), including Velan Capital Master Fund LP ("Velan Master"), pursuant to which the Issuer agreed to issue and sell to the Purchasers in a private placement shares of the Issuer's Common Stock, par value $0.01 per share (the "Common Stock"), and shares of the Issuer's Series A Convertible Preferred Stock, par value $0.01 per share (the "Series A Preferred Stock"), at a purchase price of $1.50 per share of Common Stock and $15 per share of Series A Preferred Stock. The transaction closed on August 12, 2025.

Securities owned directly by Velan Master. Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Velan Master purchased 70,012 shares of Series A Preferred Stock pursuant to the terms of the SPA and the Certificate of Designation of Rights, Preferences and Privileges of Series A Convertible Preferred Stock of Heron Therapeutics, Inc., dated August 8, 2025 (the "Certificate of Designation"). The conversion price of the Series A Preferred Stock is $1.50 per share.

Pursuant to the terms of the SPA, upon approval of the Stockholder Approval Proposal (as defined in the SPA), all of the outstanding shares of Series A Preferred Stock will automatically convert into shares of Common Stock at the applicable conversion price, plus accrued and unpaid dividends, subject to the terms and conditions set forth in the Certificate of Designation. However, the Series A Preferred Stock shall not be converted if, after giving effect thereto, Velan Master (together with its affiliates) would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 4.99% of the outstanding shares of Common Stock. Such ownership limitation may be increased upon 61 days' notice to the Issuer.


Class A Common Stock

Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.


Class B Common Stock

Class A Common Stock

Class A Common Stock

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted February 25, 2025.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.30 to $12.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.

Each Restricted Stock Unit represents a contingent right to receive one share of Class B Common Stock.

The shares of Class B Common Stock underlying the RSU award granted under the Issuer's 2011 Stock Plan vest in equal monthly installments over 48 months following September 10, 2021, subject to the Reporting Person's continued service through each vesting date.

Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock, and has no expiration date.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.42 to $104.52, inclusive. The reporting person undertakes to provide to DT Midstream, Inc., any security holder of DT Midstream, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Class A Common Stock

Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.


Non-Qualified Stock Option (right-to-buy)

Common Stock

Common Stock

Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.

Grant of option to buy shares of Issuer common stock that became exercisable in four annual installments beginning on February 14, 2020.

Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.

/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg


Premium Incentive Stock Option (right-to-buy)

Common Stock

Grant of option at a 110% premium to the closing price of Issuer common stock on the Nasdaq Global Select Market on February 12, 2021 to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.

Not applicable.

/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky


Includes restricted stock units.


The sales price is a weighted average price. Shares were sold in multiple transactions at prices ranging from $11.66 to $11.96, inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within such range upon request to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission.

Includes RSUs.

/s/Angelique Strong Marks, as Attorney-in-Fact for Matthew B. Crawford


Indirect #1: SCL TTEE of the SCL Living Trust DTD 03/30/83.

Indirect #2: By SCL Trust.

Indirect #3: By Franes R. Lindner, Trustee for the Frances R. Lindner Living Trust dated 9/13/93.

Indirect #4: By Dynasty Trust.

Indirect #5: By GST Trust.

Indirect #6: By Legacy Trust 10/30/20.

Indirect #12: Held in the Company's Retirement and Savings Plan. The number of shares of Common Stock is based on a statement dated as of 02/24/25.

S. Craig Lindner By: Joseph C. Alter, as Attorney-in-Fact


Indirect #1: CHL III, TTEE (or his Successors) of the Carl H. Lindner III Family Trust DTD 8/29/02 as Amended.

Indirect #2: Martha S. Lindner, (or her Successor) of the Martha S. Lindner Family Trust DTD 8/30/02 as amended.

Indirect #12: Seraphim Partners LLC fka CHL Investments, LLC

Indirect #13: By C3 Family Trust 2010-1

Indirect #14: C3 QAT Dtd 9/25/20.

Indirect #15: By #13 C3 Legacy Trust 12/1/20.

Carl H. Lindner, III By: Joseph C. Alter, as Attorney-in-Fact


Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are subject to a deferred delivery feature, these same terms apply to the related DERs.


Class I Common Shares, par value $0.01 per share

Effective as of June 2, 2025, in connection with a corporate reorganization transaction, BK Canada Holdings Inc. transferred all of its shares in Crescent Private Credit Income Corp. (the "Company") to its wholly-owned subsidiary SLC Asset Management ULC.  This joint filing on Form 4 is being made in order to include by amendment SLC Asset Management ULC as a joint filer along with its affiliates BK Canada Holdings Inc, Sun Life Assurance Company of Canada and Sun Life Financial Inc. with respect to the Company's securities and therefore amends the Form 4 that was previously filed by BK Canada Holdings Inc., Sun Life Assurance Company of Canada and Sun Life Financial Inc. on February 14, 2025.  As the parent holding company of BK Canada Holdings Inc., Sun Life Financial Inc. is deemed to have an indirect beneficial ownership interest in the shares directly owned by SLC Asset Management ULC, BK Canada Holding Inc.'s wholly-owned subsidiary.

In addition, as the parent holding company of Sun Life Assurance Company of Canada, Sun Life Financial Inc. is deemed to have an indirect beneficial ownership interest in the shares of the Company directly owned by Sun Life Assurance Company of Canada.


The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2025.


Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.


Common Stock

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $729.31 to $729.44, inclusive. The reporting person undertakes to provide Parker-Hannifin Corporation, any security holder of Parker-Hannifin Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1 to this Form 4.

The balance has been updated to no longer include 66.53 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.

/s/ Stephanie R. Breitenbach, Attorney-In-Fact


Common Stock

Common Stock

Common Stock

The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").

Transaction executed in multiple trades at prices ranging from $173.21 to $173.22 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Each RSU represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on each of August 9, 2023, 2024, 2025 and 2026.

The RSUs vest 1/2 on each of August 9, 2024 and 2025.

The RSUs vest 1/4 on each of August 9, 2025, 2026, 2027 and 2028.

/s/Linda Lam by Power of Attorney for Paul Darren Grasby


Class A Common Stock

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.


Co-Trustee of Hines & Ngo 2000 Family Trust dtd 4/18/00

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 3, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

Represents the weighted average purchase price. The shares were purchased at prices ranging from $27.22 to $28.14 per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer, or a security holder of Issuer, upon request.

2/15/17 PSU Grant that cliff vests on 2/18/20 based on 2019 year-end performance results. Amount reported is actual number of shares that vested and were issued on 2/18/20.

2/15/18 PSU Grant that cliff vests on 2/16/21 based on 2020 year-end performance results/approval. Amount reported is actual number of shares that vested and were issued on 2/16/21.

2/15/19 PSU Grant that cliff vests on 2/15/22 based on 2021 year-end performance results/approval. Amount reported is actual number of shares that vested and were issued on 2/15/22.

2/15/22 PSU Grant that cliff vests on 2/15/25 based on 2024 year-end performance results/approval. Amount reported is actual number of shares that vested and were issued on 2/18/25.

2/16/16 PSU Grant that cliff vests on 2/15/19 based on 2018 year-end performance results. Amount reported is actual number of shares that vested and were issued on 2/15/19.

2/16/21 PSU Grant that cliff vests on 2/16/23 based on 2022 year-end performance results. Amount reported is actual number of shares that vested and were issued on 2/16/23.

2/16/21 PSU Grant that cliff vests on 2/16/23 based on 2022 year-end performance results/approval. Amount reported is actual number of shares that vested and were issued on 2/16/23.

2/16/21 PSU Grant that cliff vests on 2/16/23.  Amount reported is actual number of shares that vested and were issued on 2/16/23.

2/15/19 RSU Time-Based Grant. Shares vest evenly over 3 years

2/18/20 RSU Time-Based Grant. Shares vest evenly over 3 years

2/15/18 RSU time-based grant. Shares vest evenly over 3 years.

2/15/22 RSU Time-Based Grant. Shares vest evenly over 3 years

2/16/21 RSU Time-Based Grant.  Shares vest evently over 2 years

2/15/17 RSU Time-Based Grant. Shares vest evenly over 3 years

2/16/16 RSU Time-Based Grant. Shares vest equally over 3 years.

RSUs time-based; granted 2/17/15

RSUs performance-based were originally filed on 3/4/2014 at the maximum performance criteria. This supplements that filing to note the actual number shares that vested based on the performance results.

RSUs time-based originally filed on 3/4/2014 were reported with RSUs performance-based and combined into one holding. This clarifies that filing and creates a separate holding for the RSUs time-based only.

RSU time-based grant 8/17/15, with 5-year vesting schedule, whereby shares to vest in equal increments over 5-years.

/s/ Stacey Rocha, attorney-in-fact for Ms. A.C. Ngo


Class A Common Stock

Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.


Class C Capital Stock

The reported price is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $82.04 to $82.20.  The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

Option is fully vested and exercisable on date of grant.


Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Shares withheld by the Issuer in payment of the withholding tax liability incurred upon the above-reported settlements of RSUs. The amount of shares withheld is based on the closing sale price on August 8, 2025.

Includes 616 shares of Common Stock purchased under the Issuer's Employee Stock Purchase Plan.

The restricted stock units vest in five equal annual installments beginning August 10, 2021.

The restricted stock units vest in five equal annual installments beginning August 10, 2022.


Represents a retention award of restricted shares scheduled to vest on August 7, 2028.

Direct total includes restricted shares of Equity Residential scheduled to vest in the future.


Class A Common Stock

Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.


Common Stock

Common Stock

Common Stock

Common Stock

Stock Option (Right to Purchase Common Stock)

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.

The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.

The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

The options are vested in full and exercisable immediately.

All share amounts reflect the 1-for-25 reverse stock split effective November 22, 2024.

/s/ Alexander M. Donaldson, by power of attorney


Common Stock, par value $0.0001 per share

/s/ James H. Romaker, by Power of Attorney


Includes 2,281 unvested shares subject to awards of director restricted stock units ("RSUs"), which vest in three equal installments on the 12, 24 and 36 month anniversaries of the grant date, subject to continued board service through each vesting date. Each RSU represents a contingent right to receive one share of Class A common stock.


Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for James Donald


The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.54 to $35.53 inclusive. The reporting person undertakes to provide to Regional Management Corp., any security holder of Regional Management Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold and the price at which such shares were sold.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.54 to $36.16 inclusive. The reporting person undertakes to provide to Regional Management Corp., any security holder of Regional Management Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold and the price at which such shares were sold.

/s/ Catherine R. Atwood, attorney-in-fact


Class A common stock par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Sarah Mensah


Class A common stock, par value $0.01

/s/ Maria Fernandez, Attorney-in-Fact for Kim Fennebresque


The Common Shares sold by the Reporting Person and reported herein were sold at a range of between $81.15 and $82.11 per share. The sale price reported above represents the weighted average sale price for the reported transaction. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.


The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.04 to $38.05 inclusive. The reporting person undertakes to provide to Kilroy Realty Corporation, any security holder of Kilroy Realty Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

/s/ Heidi R. Roth, as attorney-in-fact for Eliott Trencher


Class A common stock, par value $0.01

/s/ Maria Fernandez, Attorney-in-Fact for Alan Schumacher


Class A common stock par value $0.01

/s/ Maria Fernandez, Attorney-in-Fact for Lisa Gray


The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $8.62 to $8.67 per share. The Reporting Person will provide to the issuer, any
security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $8.65 to $8.67 per share. The Reporting Person will provide to the issuer, any
security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

/s/ Clinton Foss Attorney-in-Fact for Artie Starrs under a Limited Power of Attorney dated November 30, 2023.


Class A common stock, par value $0.01

/s/ Maria Fernandez, Attorney-in-Fact for Allen Gibson


Represents the number of shares withheld at vesting to cover required tax withholding. The fair market value of the Ethan Allen Interiors Inc. common stock, used for the purposes of calculating the number of shares to be withheld, was the closing price of Ethan Allen Interiors Inc. common stock as reported on August 11, 2025.

/s/ Matthew J. McNulty as attorney-in-fact for Douglas H. Diefenbach


Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

/s/Peter J. Rivas as attorney-in-fact for Andrew Toy


The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $9.23 to $9.29 per share. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

The Reporting Person is the sole member and sole manager of WestRiver Management LLC ("WestRiver Management") and the sole manager of Anderson Family Investments, LLC ("AFI"). As a result, the Reporting Person may be deemed to beneficially own the securities held of record by WestRiver Management, and AFI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.

/s/ Clinton Foss Attorney-in-Fact for Erik J Anderson under a Limited Power of Attorney dated January 23, 2024.


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock,par value $0.01

Class A common stock,par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on accrued performance based RSUs, which will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Anuj Dhanda


Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024.

President, Head of Global Oncology Research and Development


/s/ Jaileah X. Huddleston, Attorney-in-Fact for Rodney A. Young


The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025.


American Depositary Shares

American Depositary Shares

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.

Reflects a weighted average sale price of $34.7431 per share, at prices ranging from $34.095 to $35.00 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Reflects a weighted average sale price of $34.6363 per share, at prices ranging from $34.22 to $35.19 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The Stock Options fully vested as of October 22, 2020.


The balance has been updated to no longer include 85.53 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.

/s/ Stephanie R. Breitenbach, Attorney-In-Fact


/s/ Matthew J. McNulty as attorney-in-fact for Amy Phillips


Restricted Share Units ("RSUs") granted to the Reporting Person in connection with their service on the Issuer's Board of Directors. 100% of the RSUs shall vest on May 1, 2026, subject to the
Reporting Person's continuous service through the vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

The ordinary shares are held directly by Marker Follow-On Fund, LP ("Marker Follow-On"). Marker Follow-On Fund GP, Ltd. ("Marker Follow-On GP") is the general partner of Marker Follow-On. The Reporting Person is a director of Marker Follow-On GP and, in such capacity, has shared voting and dispositive power with respect to the shares held by Marker Follow-On. The Reporting Person disclaims beneficial ownership of such shares for purposes of Securities Exchange Act of 1934 ("Section 16"), except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The ordinary shares are held directly by Marker II LP Taboola Series E LP ("Marker II TSE"). Marker II GP, Ltd. ("Marker II GP") is the general partner of Marker II TSE. The Reporting Person is a director of Marker II GP and, in such capacity, has shared voting and dispositive power with respect to the shares held by Marker II TSE. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The ordinary shares are held directly by Marker Lantern 1 Ltd. ("Marker 1"). Marker Lantern Management Ltd. ("Marker Management") is the manager of Marker 1. The Reporting Person is a director of Marker Management and, in such capacity, has shared voting and dispositive power with respect to the shares held by Marker 1. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The ordinary shares are held directly by Marker Lantern II Ltd. ("Marker II"). Marker Lantern II Manager Ltd. ("Marker II Manager") is the manager of Marker II. The Reporting Person is a director of Marker II Manager and, in such capacity, has shared voting and dispositive power with respect to the shares held by Marker II. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Reporting Person is the sole member of this LLC.


By Grantor Retained Annuity Trust LTS 2022 GRAT A

By Grantor Retained Annuity Trust LTS 2022 GRAT B

By Grantor Retained Annuity Trust 2025 GRAT A

By Grantor Retained Annuity Trust 2025 GRAT B

Common Stock

Includes 109,939 shares (in the aggregate) distributed to the Reporting Person on January 23, 2025, as annuity distributions from the following Grantor Retained Annuity Trusts ("GRAT"): (1) GRAT 2021B; (2) GRAT 2021C; (3) LTS 2022 GRAT A; and (4) LTS 2022 GRAT B. Also includes 400,000 shares (in the aggregate) contributed by the Reporting Person, on March 12, 2025, to 2025 GRAT A and 2025 GRAT B.  The Reporting Person serves as trustee and the sole annuitant of each of the foregoing GRATs.

The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").

On January 23, 2025, 39,360 shares were distributed to the Reporting Person as annuity distributions from GRAT 2021B.

On January 23, 2025, 11,851 shares were distributed to the Reporting Person as annuity distributions from GRAT 2021C.

On January 23, 2025, 38,257 shares were distributed to the Reporting Person as an annuity distribution from LTS 2022 GRAT A.

On January 23, 2025, 20,471 shares were distributed to the Reporting Person as an annuity distribution from LTS 2022 GRAT B.

On March 12, 2025, the Reporting Person contributed 200,000 shares to 2025 GRAT A.

On March 12, 2025, the Reporting Person contributed 200,000 shares to 2025 GRAT B.

Each RSU represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on each of August 9, 2023, 2024, 2025 and 2026.

/s/Linda Lam by Power of Attorney for Lisa T. Su


Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Sharon Allen


The balance has been updated to no longer include 168.35 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.


Common Stock

Each restricted stock unit represents a contingent right to receive one share of Microchip Technology Incorporated common stock.

The restricted stock units will vest in full on August 15, 2026 as long as the individual remains a service provider through the vesting date.  Vested shares will be delivered to the reporting person upon vest.


Restricted Share Units ("RSUs") granted to the Reporting Person in connection with their service on the Issuer's Board of Directors. 100% of the RSUs shall vest on May 1, 2026, subject to the
Reporting Person's continuous service through the vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

The Reporting Person is a principal and managing partner of Evergreen Venture Partners, Ltd. ("Evergreen Venture Partners"), and is obligated to remit the proceeds of any sale of ordinary shares issued to the Reporting Person upon vesting of RSUs to Evergreen Venture Partners. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The reported shares are held directly by Evergreen V, L.P. ("Evergreen V"). Evergreen 5 GP Ltd. ("Evergreen 5") is the general partner of Evergreen V GP, LP ("Evergreen V GP"), which is the general partner of Evergreen V. Evergreen Venture Partners is the sole shareholder of Evergreen 5. The Reporting Person is a principal and managing partner of Evergreen Venture Partners, and disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The reported shares are held directly by Evergreen VA, L.P. ("Evergreen VA"). Evergreen 5 is the general partner of Evergreen V GP, which is the general partner of Evergreen VA. Evergreen Venture Partners is the sole shareholder of Evergreen 5. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The reported shares are held directly by Evergreen V GP. Evergreen 5 is the general partner of Evergreen V GP. Evergreen Venture Partners is the sole shareholder of Evergreen 5. The Reporting Person is a principal and managing partner of Evergreen Venture Partners, and disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.


Represents the number of shares withheld at vesting to cover required tax withholding. The fair market value of the Ethan Allen Interiors Inc. common stock, used for the purposes of calculating the number of shares to be withheld, was the closing price of Ethan Allen Interiors Inc. common stock as reported on August 11, 2025.

/s/ Matthew J. McNulty as attorney-in-fact for M. Farooq Kathwari


Shares held Indirectly, by Trust and by Family Limited Partnership.

Common Stock

Of the 10,161,135 shares held, 4,255,263 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.

The restricted stock units will vest in full on May 15, 2028 as long as the individual remains a service provider through the vesting date.  Vested shares will be delivered to the reporting person upon vest.


Common Stock


Restricted Share Units ("RSUs") granted to the Reporting Person in connection with their service on the Issuer's Board of Directors. 100% of the RSUs shall vest on May 1, 2026, subject to the Reporting Person's continuous service through the vesting date. The RSUs, subject to vesting, will not convert to ordinary shares until the satisfaction of an additional time-based settlement condition to occur in 2027. The settlement is not conditioned on the Reporting Person's provision of service on settlement date. Each RSU represents the right to receive one ordinary share upon vesting and settlement

Includes 59,172 vested RSUs. The RSUs will not convert to ordinary shares until the satisfaction of an additional time-based settlement condition to occur in 2026. The settlement is not conditioned on the Reporting Person's continuous service through the vesting date. Each RSU represents the right to receive one ordinary share upon settlement.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $22.20-$22.51, inclusive. The reporting person hereby
undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.


By Grantor Retained Annuity Trust Hu 2025 GRAT-1

Common Stock

Common Stock

Includes 25,000 shares contributed by the Reporting Person, on March 11, 2025, to a Grantor Retained Annuity Trust ("GRAT"). The Reporting Person serves as trustee and the sole annuitant of Hu 2025 GRAT-1.

The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").

On March 11, 2025, the Reporting Person contributed 25,000 shares to Hu 2025 GRAT-1.

Each RSU represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on each of August 9, 2024, 2025, 2026 and 2027.

The RSUs vest 1/4 on each of August 9, 2025, 2026, 2027 and 2028.


Trust established for benefit of Children

/s/ Helen Kaminski, pursuant to power of attorney previously filed


Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Frank Bruno


The reported securities were sold in an underwritten public offering and concurrent private placement at a price of $19.50 per share of common stock of the Issuer.

/s/ Catherine M. Mazzeo, Senior Vice President/Chief Legal, Safety & Compliance Officer and Corporate Secretary


The balance has been updated to no longer include 375.93 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.


Restricted Share Units ("RSUs") granted to the Reporting Person in connection with their service on the Issuer's Board of Directors. 100% of the RSUs shall vest on May 1, 2026, subject to the
Reporting Person's continuous service through the vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Shares held by a trust for which the Reporting Person's spouse is the beneficiary. Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any.


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on accrued performance based RSUs, which will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Robert Bruce Larson


Restricted Share Units ("RSUs") granted to the Reporting Person in connection with their service on the Issuer's Board of Directors. 100% of the RSUs shall vest on May 1, 2026, subject to the Reporting Person's continuous service through the vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on accrued performance based RSUs, which will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Sharon McCollam


Common Stock

/s/Linda Lam by Power of Attorney for Ava Hahn


Class A Common Stock

Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.

/s/ Priscilla Duncan-Tannous, Attorney-in-Fact


The Reporting Person is affiliated with Pitango Venture Capital ("Pitango"). Pitango related entities are shareholders in the Issuer. Other Pitango fund managers have a pecuniary interest in the reported shares. The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The reported shares are held directly by Pitango Venture Capital Fund VI, L.P. ("Pitango Fund VI, L.P."). Pitango V.C. Fund VI, L.P. ("Pitango GP") serves as the sole general partner of Pitango Fund VI, L.P. The Reporting Person is a Managing Partner of Pitango GP and, in such capacity, has shared voting and dispositive power with respect to the shares held by Pitango Fund VI, L.P. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The reported shares are held directly by Pitango Venture Capital Fund VI-A, L.P. ("Pitango Fund VI-A, L.P."). Pitango GP serves as the sole general partner of Pitango Fund VI-A, L.P. The Reporting Person is a Managing Partner of Pitango GP and, in such capacity, has shared voting and dispositive power with respect to the shares held by Pitango Fund VI-A, L.P. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

The reported shares are held directly by Pitango Venture Capital Principals Fund VI, L.P. ("Pitango Principals Fund VI, L.P."). Pitango GP serves as the sole general partner of Pitango Principals Fund VI, L.P. The Reporting Person is a Managing Partner of Pitango GP and, in such capacity, has shared voting and dispositive power with respect to the shares held by Pitango Principals Fund VI, L.P. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Thomas Moriarty


The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2025.


Common Stock

Common Stock

Common Stock

The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").

Each RSU represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on each of August 9, 2023, 2024, 2025 and 2026.

The RSUs vest 1/4 on each of August 9, 2024, 2025, 2026 and 2027.

The RSUs vest 1/4 on each of August 9, 2025, 2026, 2027 and 2028.


Common Stock

The balance has been updated to no longer include 19.60 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

/s/ Maria Fernandez, Attorney-in-Fact for Susan Morris


Common Stock

All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $157.2350 to a high of $158.1800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $158.3100 to a high of $159.0000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $733.01 to $733.87, inclusive. The reporting person undertakes to provide Parker-Hannifin Corporation, any security holder of Parker-Hannifin Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1 to this Form 4.

Includes the grant of 1,000 Restricted Stock Units granted in November 2023 which will vest in November 2026.


The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a Restricted Stock Units award. Not an open market sale of securities.


Common Stock

Common Stock

/s/Linda Lam by Power of Attorney for Philip Guido


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on accrued performance based RSUs, which will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Jennifer Saenz


The balance has been updated to no longer include 169.28 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.


Common Stock

Insight Enterprises, Inc. has withheld the number of whole shares necessary to satisfy the minimum statutory tax withholding obligations.  The value of the vested shares (and the taxable income) is calculated based on the closing price on the vesting date or next preceding trading date in the case that the vesting date is a non-trading date.

Each restricted stock unit represents a contingent right to receive one share of Common Stock of Insight Enterprises, Inc.

The restricted stock units were granted on August 10, 2021 with vesting to occur in four equal annual installments beginning August 10, 2022.

Lisanne Steinheiser, by Power of Attorney, for Robert Douglas Green


The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 5, 2024.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.49 to $14.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $12.73  to $13.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The shares are held of record by Dustin A. Moskovitz TTEE Dustin A. Moskovitz Trust DTD 12/27/05.


Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Michael Theilmann


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $176.30 to $176.59 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range.

Includes shares acquired by the reporting person through the Company's Employee Stock Purchase Plan since the last reported transaction.

/s/ Ramune M. Kligys by PoA of Stephen Edward Hull


By Versant Venture Capital V (Canada) LP

By Versant Ophthalmic Affiliates Fund I, L.P.

Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation ("Purchaser") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the "Offer")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest.

Shares are held by Versant Venture Capital V, L.P. ("Versant V"). Versant Ventures V, LLC ("Versant V GP") is the sole general partner of Versant V. Jerel C. Davis ("Dr. Davis"), a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Versant V, and each disclaims beneficial ownership of the shares held by Versant V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.

Shares are held by Versant Venture Capital V (Canada) LP ("Canada V"). Versant Ventures V (Canada), L.P. ("Canada V GP") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. ("Canada V GP-GP") is the sole general partner of Canada V GP. Dr. Davis, a member of the Issuer's board of directors, is a director of Canada V GP-GP. Each of Canada V GP-GP, Canada V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Canada V, and each disclaims beneficial ownership of the shares held by Canada V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.

Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. ("Ophthalmic"). Versant V GP is the sole general partner of Ophthalmic. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Ophthalmic, and each disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.

Shares are held by Versant Affiliates Fund V, L.P. ("Affiliates V"). Versant V GP is the sole general partner of Affiliates V. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Affiliates V, and each disclaims beneficial ownership of the shares held by Affiliates, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.

Shares held by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC ("Vantage II GP-GP") is the sole general partner of Vantage II GP. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP. Each of Vantage II GP-GP, Vantage II GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Vantage II, and each disclaims beneficial ownership of the shares held by Canada V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.


Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.


The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a Restricted Stock Units award. Not an open market sale of securities.

Includes 9,017 shares acquired through the company's Employee Stock Purchase Plan on June 9, 2025.

/s/ Allison Koehler, Attorney in Fact for Brian Dostie


Common Stock

Common Stock

Common Stock

The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").

Each RSU represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on each of August 9, 2023, 2024, 2025 and 2026.

The RSUs vest 1/4 on each of August 9, 2024, 2025, 2026 and 2027.

The RSUs vest 1/4 on each of August 9, 2025, 2026, 2027 and 2028.

/s/ Linda Lam By Power of Attorney for Mark Papermaster


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2024, which was entered into primarily to satisfy certain tax obligations.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $ 27.65 to $28.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The shares are held of record by the Gaurav Anand 2021 Trust, for which the Reporting Person's spouse serves as the trustee.

/s/ Ruby Alexander, Attorney-in-Fact for Gaurav Anand


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $732.16 to $733.14, inclusive. The reporting person undertakes to provide Parker-Hannifin Corporation, any security holder of Parker-Hannifin Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1 to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $733.17 to $733.21, inclusive. The reporting person undertakes to provide Parker-Hannifin Corporation, any security holder of Parker-Hannifin Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.

The balance has been updated to no longer include 708.37 shares of phantom stock in the Savings Restoration Plan that have historically been reported in Table I but instead were reportable in Table II. Each share of phantom stock that was acquired under the Savings Restoration Plan is the economic equivalent of one common share and is settled in cash. The shares of phantom stock generally become payable following the reporting person's separation from service.

/s/ Stephanie R. Breitenbach, Attorney-in-Fact


Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Brian Kevin Turner


/s/ Alexandra Cotter Wilkins, Attorney-in-Fact


/s/ Allison Koehler, Attorney in Fact for Michael Black


/s/ Leland D. Melvin, by Theresa B. Taylor, attorney-in-fact


Class A common stock, par value $0.01

Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent of $0.15 per share of common stock.

/s/ Maria Fernandez, Attorney-in-Fact for Mary Beth West


By Derek Maetzold 2020 Irrevocable Trust

By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk

By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold

By The Maetzold 2018 Remainder  Trust FBO John Derek Maetzold

By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

By DJM Grantor Retained Annuity Trust No. 5

By DJM Grantor Retained Annuity Trust No. 6

By DJM Grantor Retained Annuity Trust No. 7

Common Stock

Reflects the transfers on July 11, 2025, of 36,907 shares of common stock from DJM Grantor Annuity Trust No. 5 and 7,416 shares of common stock from DJM Grantor Annuity Trust No. 6 to the Reporting Person's direct holdings, and the transfer on July 14, 2025, of 44,323 shares of common stock from the Reporting Person's direct holdings to DJM Grantor Annuity Trust No. 7.

Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary.

Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Held by DJM Grantor Retained Annuity Trust No. 5 of which the Reporting Person is the trustee and beneficiary.

Held by DJM Grantor Retained Annuity Trust No. 6 of which the Reporting Person is the trustee and the beneficiaries are The Maetzold 2018 Remainder Trust FBO John Derek Maetzold, The Maetzold 2018
Remainder Trust FBO Emily Carol Kirk, The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold and The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold.

Held by DJM Grantor Retained Annuity Trust No. 7 of which the Reporting Person is the trustee and beneficiary.

Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024.


Common Stock

Common Stock

Common Stock

The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").

Each RSU represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on each of August 9, 2023, 2024, 2025 and 2026.

The RSUs vest 1/4 on each of August 9, 2024, 2025, 2026 and 2027.

The RSUs vest 1/4 on each of August 9, 2025, 2026, 2027 and 2028.


The transaction reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan entered into on December 6, 2024.

/s/ Cesare Suardi, Attorney-in-Fact for Sanjeev Aggarwal


Common Stock

The reporting person will receive a cash payment for each phantom stock unit equal to the fair market value on the vesting date of one share of the Company's common stock. The reporting person elected to receive the 2025 annual equity award for directors in phantom stock units.

/s/ Joshua Sidsworth, Attorney-In-Fact for Johnny Hartnett


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.785 to $3.95, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Includes 622,833 restricted stock units which are payable in an equivalent number of shares of the Issuer's common stock.


Common Stock

The price in Column 4 is a weighted average price. The shares sold at prices ranging from $177.2700 to $177.5950 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Stock option vests in three equal annual installments beginning February 27, 2024.

/s/ Ronald O. Whitford Jr., by Theresa B. Taylor, attorney-in-fact


/s/ Stephanie J. Pacitti, attorney-in-fact for Corning F. Painter


Common Stock


The securities reported are shares of restricted stock that vest on August 8, 2026. The reporting person elected to receive the 2025 annual equity award for directors in shares of restricted stock.

/s/ Joshua Sidsworth, Attorney-In-Fact for Carlos Ruisanchez


Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

/s/ Jessica Causey, Attorney-IN-Fact for Andrea Frohning


Voluntary Cash for DRIP.

The ending balance differs from amounts previously reported due to shares acquired under a dividend reinvestment plan.


By Tobin W and Susan M Juvenal Family Revocable Trust

Common Stock

Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries.

Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024.


shares purchased via automatic dividend reinvestment through brokerage account


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.945 to $16.97, inclusive. The reporting person undertakes to provide to PENN Entertainment, Inc., any security holder of PENN Entertainment, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

/s/ Joshua Sidsworth, Attorney-In-Fact for David A. Handler


The purchases reported herein were effected pursuant to a Rule 10b5-1 plan adopted by Hill City Holdings, LP ("Hill City") on June 5, 2025.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $12.16 to $13.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The securities are held of record by Hill City. ECP ControlCo, LLC is the managing member of Energy Capital Partners IV, LLC, which is the general partner of Energy Capital Partners GP IV, LP, which is the general partner of each of (i) Energy Capital Partners IV-A, LP, (ii) Energy Capital Partners IV-B, LP, (iii) Energy Capital Partners IV-C, LP, and (iv) Energy Capital Partners IV-D, LP (the "Funds"). Energy Capital Partners GP IV, LP is also the general partner of Energy Capital Partners IV-B (Hill City IP), LP ("Hill City IP"). Each of (i) Energy Capital Partners IV-A, LP, (ii) Hill City IP, (iii) Energy Capital Partners IV-C, LP, and (iv) Energy Capital Partners IV-D, LP are the members of Hill City Holdings GP, LLC, which is the general partner of Hill City.

ECP ControlCo, LLC is controlled by its board of managers, which consists of Douglas Kimmelman, Peter Labbat, Tyler Reeder, Rahman D'Argenio, Raoul Hughes and Xavier Robert, all of whom collectively share the power to vote and dispose of the securities beneficially owned by ECP ControlCo, LLC. As a result of these relationships, each of the foregoing entities and individuals may be deemed to share beneficial ownership of the securities held of record by Hill City. Each such entity and individual disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $12.265. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Due to filing limitations of the electronic filing system, each of ECP Fiber Holdings GP, LLC, ECP Fiber Holdings, LP, Hill City Holdings GP, LLC and Hill City Holdings, LP are filing a separate Form 4.


Due to filing limitations of the electronic filing system, each of ECP ControlCo, LLC, Energy Capital Partners IV, LLC, Energy Capital Partners GP IV, LP, Energy Capital Partners IV-A, LP, Energy Capital Partners IV-B, LP, Energy Capital Partners IV-C, LP, Energy Capital Partners IV-D, LP and Energy Capital Partners IV-B (Hill City IP), LP are filing a separate Form 4.


Series A Perpetual Stretch Preferred Stock

The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $97.53 to $97.73, inclusive. The reporting person undertakes to provide to Strategy Inc, any security holder of Strategy Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.


This transaction was executed in multiple trades at prices ranging from $1.60 to $1.575 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.827 to $52.91 per share, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 2,290 restricted stock units.

/s/ Catherine H. Claiborne, attorney-in-fact


The Transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024.

/s/ Bryan Tham, Attorney-in-Fact for Elizabeth M O'Callahan


Reflects performance share units that will settle on August 15, 2025.


Common Stock

Option granted automatically on Mr. Bracke's reelection to NVE's Board of Directors.


These shares were acquired through exempt dividend reinvestment transactions and are being voluntarily reported.


The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.6300 to $5.7400, inclusive. The reporting person undertakes to provide to Cricut Inc., any security holder of Cricut Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.6750 to $5.6950, inclusive. The reporting person undertakes to provide to Cricut Inc., any security holder of Cricut Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Shares withheld by Registrant to satisfy tax withholding obligations on vesting of restricted stock units.

/s/ Patricia A. Comai POA for David K. Wells


Common Stock

Mr. Webb's Form 4 filed on July 16, 2025, inadvertently stated the incorrect number of restricted stock units ("RSUs") which vested on July 12, 2025 and were settled in exchange for a like amount of shares of common stock, par value $0.01 per share ("Common Stock") of J.Jill, Inc, and the number of shares withheld to satisfy tax withholding obligations. This Form 4 reflects the corrected total beneficial ownership for Mr. Webb.

Each RSU represents a contingent right to receive one share of Common Stock of J.Jill, Inc.


Class A Common Stock

Fully vested.


Represents shares of Class A common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

These securities are held by the Reporting Person's spouse.

These securities are held by a trust of which the Reporting Person's spouse is the trustee.


Mandatory sale to cover tax liability associated with the settlement of market stock units.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.08 to $8.19 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.


Restricted Stock Units (MSPP Purchased Award)

Common Stock

Restricted Stock Units (MSPP Matching Award)

Common Stock

Restricted stock units (MSPP Purchased Award) are fully vested upon grant; however, settlement occurs upon the earlier of termination of employment or three years from grant date.

Represents settlement date for restricted stock units (MSPP Purchased Award). Restricted stock units do not expire; they either vest or are canceled prior to vesting date.

Represents vesting date for these restricted stock units.

Reporting person was awarded the restricted stock units (MSPP Matching Award) in connection with voluntary participation in a management stock purchase program (MSPP).


/s/ Victor L. Cangelosi, pursuant to power of attorney


Contributions to non-profit organizations.

/s/ by Mark F. Hoffman as attorney-in-fact for Douglas J. Herrington, CEO Worldwide Amazon Stores